EPND-12. TYROSINE KINASE INHIBITORS AXITINIB, IMATINIB AND PAZOPANIB ARE SELECTIVELY POTENT IN EPENDYMOMA

Reproducibly effective chemotherapy has yet to be identified for ependymoma (EPN), partly due to a lack of models for preclinical drug screening. Treatment of EPN has therefore changed little over the last 40 years and is essentially limited to surgery and radiation. Recurrence risk is high, particu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Donson, Andrew, Werner, Elliot, Amani, Vladimir, Griesinger, Andrea, Witt, Davis, Nellan, Anandani, Vibhakar, Rajeev, Hankinson, Todd, Handler, Michael, Dorris, Kathleen, Foreman, Nicholas
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2017
Assuntos:
Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5475033/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox083.070
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados